REGEN BIOPHARMA, INC. Proceeds from (Repurchase of) Equity
REGEN BIOPHARMA, INC. (RGBP) reported Proceeds from (Repurchase of) Equity of $535.56 thousand for the 9-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepurchaseOfEquity · last filed 2024-08-13
- 2024-06-30: Proceeds from (Repurchase of) Equity 9 month $535.56K.
| Period end | Proceeds from (Repurchase of) Equity 9 month |
|---|---|
| 2024-06-30 | $535.56K 10-Q · filed 2024-08-13 |